US 8697628
Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes
granted A61KA61K31/05A61K31/155
Quick answer
US patent 8697628 (Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes) held by The Regents of the University of Colorado, a Body Corporate expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/05, A61K31/155, A61K31/353, A61K31/549